A clinical trial of gene therapy for chronic pain.
Pain Med
; 10(7): 1325-30, 2009 Oct.
Article
en En
| MEDLINE
| ID: mdl-19818042
ABSTRACT
The first human trial of gene therapy for chronic pain, a phase 1 study of a nonreplicating herpes simplex virus (HSV)-based vector engineered to express preproenkephalin in patients with intractable pain from cancer, began enrolling subjects in December 2008. In this article, we describe the rationale underlying this potential approach to treatment of pain, the preclinical animal data in support of this approach, the design of the study, and studies with additional HSV-based vectors that may be used to develop treatment for other types of pain.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dolor
/
Terapia Genética
/
Ensayos Clínicos como Asunto
/
Manejo del Dolor
Límite:
Humans
Idioma:
En
Revista:
Pain Med
Asunto de la revista:
NEUROLOGIA
/
PSICOFISIOLOGIA
Año:
2009
Tipo del documento:
Article
País de afiliación:
Estados Unidos